A systematic review of the histopathologic survey on skin biopsies in patients with Corona Virus Disease 2019 (COVID‐19) who developed virus or drug‐related mucocutaneous manifestations. Issue 9 (24th May 2021)
- Record Type:
- Journal Article
- Title:
- A systematic review of the histopathologic survey on skin biopsies in patients with Corona Virus Disease 2019 (COVID‐19) who developed virus or drug‐related mucocutaneous manifestations. Issue 9 (24th May 2021)
- Main Title:
- A systematic review of the histopathologic survey on skin biopsies in patients with Corona Virus Disease 2019 (COVID‐19) who developed virus or drug‐related mucocutaneous manifestations
- Authors:
- Najar Nobari, Niloufar
Seirafianpour, Farnoosh
Dodangeh, Milad
Sadeghzadeh‐Bazargan, Afsaneh
Behrangi, Elham
Mozafarpoor, Samaneh
Goodarzi, Azadeh - Abstract:
- Abstract: The mucocutaneous manifestations of Corona Virus Disease 2019 (COVID‐19) logically may reflect systemic visceral involvements. These findings are visible and easy to approach like biopsies for exact histopathologic evaluations. This systematic review was conducted to collect the mucocutaneous histopathologic data of COVID‐19 patients for future investigations and interpretations. The COVID‐19 dermatology resource of the Centre of Evidence‐Based Dermatology (CEBD) at the University of Nottingham, PubMed, Scopus, Google Scholar and Medscape was searched for relevant English articles published by June 3, 2020. This review included 31 articles, involving 459 patients. The common primary virus‐related mucocutaneous manifestations are easy to approach in the course of COVID‐19. The authors of this study supposed dermatopathological findings as the predictors of the nature of potential systemic involvements and outcomes of COVID‐19. Scrutinizing these findings can help with adopting more effective therapeutic and management strategies; nevertheless, this review found the severity and time of onset of symptoms not to be associated with the laboratory and histopathological findings. Deterioration of clinical conditions and laboratory tests was also not related to the histopathological findings. It is recommended that meta‐analyses be conducted in the future to detail on these data for having more comprehensive and better conclusion.
- Is Part Of:
- Experimental dermatology. Volume 30:Issue 9(2021)
- Journal:
- Experimental dermatology
- Issue:
- Volume 30:Issue 9(2021)
- Issue Display:
- Volume 30, Issue 9 (2021)
- Year:
- 2021
- Volume:
- 30
- Issue:
- 9
- Issue Sort Value:
- 2021-0030-0009-0000
- Page Start:
- 1233
- Page End:
- 1253
- Publication Date:
- 2021-05-24
- Subjects:
- biopsy -- coronavirus -- COVID‐19 -- cutaneous -- dermatology -- histopathology -- mucocutaneous -- pathology -- SARS‐CoV‐2 -- skin -- systematic review
Dermatology -- Periodicals
616.5 - Journal URLs:
- http://www.blackwellpublishing.com/journal.asp?ref=0906-6705&site=1 ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1600-0625 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/exd.14384 ↗
- Languages:
- English
- ISSNs:
- 0906-6705
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3839.070000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 18942.xml